MedPage Today December 22, 2025
Major companies promise to rein in Medicaid drug prices
President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.
Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi will now rein in Medicaid drug prices to match what they have charged in other developed countries.
As part of the deal, new drugs made by those companies will also be charged at the so-called “most favored nation” pricing across the country on any newly launched medications, including commercial and cash pay markets as well as Medicare and Medicaid.
Drug prices for patients in the U.S. can depend on a number of factors, including...
Today's Sponsors
Today's Sponsor